IDEXX Laboratories Sees FY24 EPS $10.82-$11.20 Vs $12.69 Estimate
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories projects its FY24 EPS to be between $10.82 and $11.20, which is below the analyst estimate of $12.69. This forecast suggests a potential downturn in earnings compared to expectations.
May 01, 2024 | 10:38 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IDEXX Laboratories projects its FY24 EPS significantly below analyst expectations, indicating a potential earnings downturn.
The projected EPS for FY24 by IDEXX Laboratories is significantly lower than the analyst estimates, which could lead to negative investor sentiment and a potential decrease in stock price in the short term. This discrepancy between projected and expected earnings is critical for investors as it directly impacts the perceived value and future profitability of the company.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100